This is borne out by the considerably greater completion rates that are being consistently reported for the shorter R&R2 programs, the impact of which should not be underestimated in offenders given the association between completion rates, lower reconviction rates and ultimately public protection.
gDNA exhibited significantly greater STR genotype completion rate than did 1 ng gDNA input (p < 0.001).
gDNA exhibited STR genotype completion and concordance rates of 100%, which were significantly greater than the completion rate exhibited by wgaDNA produced from 1 ng gDNA input and the wgaDNA concordance produced from all gDNA inputs, respectively (Table 1).
However, this recommendation was primarily based on achievement of greater than 80% completion rate of clinical trials, which in turn may be influenced by the length of the trials.
Among those with the greatest discrepancy, the lower completion rate for cervical dilation on admission likely resulted from clarifications that arose during the training period about criteria required to abstract this variable.
Neither arm demonstrated a treatment completion rate statistically greater than 60%, which was the predefined feasibility criterion.
Both arms just failed to meet the predefined feasibility criterion of a treatment completion rate statistically greater than 60% (arm A 71%, 90% CI 58 81%, P=0.079; arm B 67%, 90% CI 55 78%, P=0.184).
Consistent with the findings of Rees-Jones et al. [ 43], it was hypothesised that the completion rate would be greater than the 50% reported by Cullen et al. [ 35] in their study using the original 36 session R&R program.
None of the arms demonstrated a completion rate that was statistically greater than 60% (P=0.102, P=0.056, P=0.982), which was our formal feasibility criteria; the completion rate in arm C is markedly less than this level.
